Pharmaceuticals

Sarepta Therapeutics is one of the most important rare disease and neuromuscular gene therapy developers. The company is strongly associated with Duchenne muscular dystrophy, where it has developed RNA-based exon-skipping therapies and gene therapy approaches for severe neuromuscular disease.

Sanofi is one of the world’s leading vaccine companies and a major participant in immunology. Its vaccine business, historically associated with Sanofi Pasteur, spans influenza, pediatric vaccines, meningococcal disease, travel vaccines, and respiratory disease prevention.

Sana Biotechnology is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Samsung Biologics is one of the most important biologics CDMO providers globally and a defining player in large-scale mammalian cell culture manufacturing. The company has built a highly standardized, large-capacity manufacturing platform in South Korea, serving major pharmaceutical and biotechnology clients across biologics development and commercial supply.

Rocket Pharmaceuticals is a specialist gene therapy company focused on rare diseases, including hematologic, immunologic, and cardiovascular genetic disorders. The company uses both lentiviral and AAV-based approaches, giving it modality diversity within genetic medicine.

Rhythm Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Revolution Medicines is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Rentschler Biopharma is a specialist biologics CDMO focused on process development, clinical manufacturing, commercial manufacturing, analytical development, and regulatory support for biopharmaceutical products. The company has a long history in biologics manufacturing and serves sponsors across Europe, North America, and other markets.

Regenxbio is an established gene therapy company focused on adeno-associated virus vectors and genetic medicine. The company has built its platform around AAV delivery technology and has programs in rare disease, ophthalmology, neurodegenerative disease, and other inherited disorders.

Regeneron Pharmaceuticals is one of the strongest research-driven biotechnology firms globally, known for its antibody discovery capabilities, internal science culture, and successful commercial products across ophthalmology, immunology, oncology, and rare diseases.

Recordati Rare Diseases is a focused orphan drug platform within Recordati, serving patients with rare endocrine, metabolic, oncologic, and inherited disorders. The business has built a portfolio of specialty medicines for diseases requiring specialist diagnosis and long-term management.

Recipharm is a European CDMO with a broad pharmaceutical manufacturing platform spanning sterile manufacturing, oral solid dose, inhalation products, analytical services, development, and commercial supply. The company serves pharmaceutical and biotechnology sponsors across multiple dosage forms and therapeutic categories.

PTC Therapeutics is an established rare disease company focused on neurological, neuromuscular, metabolic, and genetically defined disorders. The company has developed therapies for rare diseases such as Duchenne muscular dystrophy and aromatic L-amino acid decarboxylase deficiency, among other programs.

PSI CRO is a privately held full-service CRO with a strong reputation in clinical trial execution, particularly for sponsors seeking operational focus, therapeutic expertise, and global study management. The company supports Phase II–III and related clinical development programs across multiple therapeutic areas.

ProPharma is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Premier Research is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Thermo Fisher Scientific, through PPD and related clinical research services, is one of the largest and most strategically important CRO platforms globally. Its strength lies in the combination of clinical trial execution, laboratory services, life sciences tools, manufacturing support, and scientific infrastructure.

WuXi AppTec is one of the most important contract research and development platforms globally, with broad services across discovery chemistry, biology, preclinical testing, clinical research, laboratory testing, and enabling technologies for pharmaceutical and biotechnology clients.

Roche remains one of the most important pharmaceutical companies globally, with deep institutional strength in oncology, immunology, neuroscience, ophthalmology, and precision medicine. Its pharmaceutical business is supported by one of the world’s strongest diagnostics platforms, giving Roche a differentiated position at the intersection of therapeutics, biomarkers, companion diagnostics, and personalized healthcare.

LabConnect is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Clinical Trial & Research Laboratories 2 ranking categories Overview